文献速递消化道肿瘤与早癌消化内镜

粪便免疫化学检测在息肉病史及结直肠癌家族史人群中的性能:系统综述

Performance of Fecal Immunochemical Test in Individuals With Personal History of Polyps and Family History of Colorectal Cancer: A Systematic Review.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-09-16

该系统综述评估一次性粪便免疫化学检测(FIT)在息肉切除术后监测及结直肠癌家族史人群中的诊断性能。共纳入3项研究8817例息肉病史者及12项研究5525例家族史者,FIT对结直肠癌检测灵敏度与特异度范围宽泛,受阈值和组织学影响。现有证据不足以充分评估FIT在这两类高风险人群中的诊断性能。

要点

  • 息肉病史者一次性FIT检测结直肠癌灵敏度27.6%–100.0%,特异度55.9%–94.1%。
  • 结直肠癌家族史者一次性FIT灵敏度25.0%–100.0%,特异度83.1%–92.0%。
  • 现有证据有限,不足以充分评估FIT在息肉术后监测或家族史人群中的性能。

核心结论

  • 当前证据有限,不足以充分评估FIT在结直肠癌家族史人群或息肉切除术后随访中的诊断性能。

研究设计与样本

  • 系统综述,全面检索多个数据库,纳入报告一次性FIT作为筛查或监测工具在结直肠癌高风险人群中性能的研究。
  • 纳入3项研究共8817例有息肉个人史并接受FIT检测的个体。
  • 纳入12项研究共5525例有结直肠癌家族史的个体。

主要发现

  • 息肉个人史者中,一次性FIT检测结直肠癌的灵敏度范围为27.6%至100.0%,特异度范围为55.9%至94.1%,检测阈值和指数息肉组织学各异。
  • 结直肠癌家族史者中,一次性FIT的灵敏度范围为25.0%至100.0%,特异度范围为83.1%至92.0%,检测阈值和家族史特征各异。

局限性

  • 现有证据仅限于少数研究,不足以充分评估FIT在家族史人群或息肉切除术后随访中的诊断性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: There is limited information regarding performance of fecal immunochemical test (FIT) in post-polypectomy surveillance, or for screening individuals with a family history of colorectal cancer (CRC). We conducted a systematic review to assess current evidence regarding diagnostic performance of one time FIT in increased risk populations. METHODS: A comprehensive search of multiple databases was conducted to assess studies reporting performance of a one-time FIT as screening or surveillance tool in individuals at increased risk of CRC. RESULTS: We identified 3 studies reporting on 8817 individuals with personal history of polyps who underwent FIT testing. For CRC detection, one-time FIT showed sensitivity ranging from 27.6% to 100.0% and specificity ranging from 55.9% to 94.1% with variable test thresholds and index polyp histology. We identified 12 studies reporting on 5525 individuals with family history of CRC. One-time FIT showed a sensitivity ranging from 25.0% to 100.0% and specificity ranging from 83.1% to 92.0%, with variable test thresholds and family history characteristics. CONCLUSIONS: Current evidence is limited to adequately assess diagnostic performance of FIT in individuals with family history of CRC, or as follow-up after polypectomy.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Karna R, Bilal M, Nayfeh T, et al. Performance of Fecal Immunochemical Test in Individuals With Personal History of Polyps and Family History of Colorectal Cancer: A Systematic Review. Clin Gastroenterol Hepatol. 2025. PMID: 40967445. doi:10.1016/j.cgh.2025.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。